BROAD PORTFOLIO THROUGH BROAD EXPERTISE

RD&C combines diverse academic and scientific background with broad expertise and long experience in pharmaceutical industry and offers a highly specified and exceptional portfolio to its clients.

Drug discovery and development process – from target validation to clinical phase

 

Stability, impurities and degradation products – from identification to justification

 

Regulatory documentation – IND, DMF, QOS, CTD, ERA

 

Regulatory advice – deficiency letters, expert statement, regulatory strategies

 

Environmental Risk Assessments – a new approach to prepare ERAs

 

In silico toxicology assessment – from impurity profiling to ERA

 

Commercial evaluation of drug development projects – from idea to market

 

Quality Management Support – from control to audit

 

Audits – GMP and supplier audits

 

Support for CRO selection – from request to match

 

Statistics – an inevitable tool in drug development

 

IP management – from claims to product portfolio

 

RD&C network – from academia to industry

 

Publication & scientific talks – RD&C’s scientific activities